Active Ingredient/Content
|
Efficacy/Indication
- Short-term (a few weeks) adjunct to weight reduction regimen based on exercise, behavioral modification, and caloric restriction in the management of exogenous obesity for patients with an initial BMI ¡Ã30kg/§³ or ¡Ã27kg/§³ in the presence of other risk factors (eg, controlled HTN, diabetes, hyperlipidemia).
|
Administration/Dosage
- Adults(>16 yrs): Individualize dose. Usual: 1 tab ud in am. Avoid taking dose in evening.
- Elderly: Start at lower end of dosing range.
|